← Back
Data updated: Mar 10, 2026
MORTON GROVE
GastroenterologyCardiovascular
MORTON GROVE is a generic drug manufacturer focused on Gastroenterology, Cardiovascular.
1989
Since
16
Drugs
-
Trials
76
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
NYSTATIN 2026-02-05
HALOPERIDOL 2025-12-18
TRIAMCINOLONE ACETONIDE 2025-10-17
TRIAMCINOLONE ACETONIDE 2025-10-08
Labeling
METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01
Labeling
METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01
Labeling
SODIUM POLYSTYRENE SULFONATE 2025-06-10
TRIAMCINOLONE ACETONIDE 2025-04-11
TRIAMCINOLONE ACETONIDE 2025-04-03
Labeling
NYSTATIN 2025-03-21
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 67%
2 drugs
Cardiovascular 33%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (12)
Company Info
- First Approval
- 1989-05-25
- Latest
- 1996-03-01
- Applications
- 22